Lv5
830 积分 2025-04-27 加入
Some Possible Confounders in Study of Patient Age and Progression of Low-risk Papillary Thyroid Carcinoma
16天前
已完结
The Usefulness of the International Grading System in the Management of Sporadic Medullary Thyroid Carcinoma
17天前
已完结
Use of Neoadjuvant Vandetanib in Aggressive Pediatric Medullary Thyroid Carcinoma
26天前
已关闭
Postoperative Radiotherapy for Medullary Thyroid Cancer: A Meta‐Analysis of Survival and Recurrence Outcomes
1个月前
已完结
Insights into highly selective RET inhibitors in medullary thyroid cancer
1个月前
已完结
Biomarker identification of medullary thyroid carcinoma from gene expression profiles considering without-treatment and with-treatment studies—A bioinformatics approach
1个月前
已完结
Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancers
2个月前
已完结
Precision treatment guided by patient-derived organoids-based drug testing for locally advanced thyroid cancer: a single arm, phase 2 study
2个月前
已完结
Neoadjuvant therapy to improve resectability of advanced thyroid cancer: A real‐world experience
2个月前
已完结
The potential role of neoadjuvant treatment in thyroid cancers in the era of kinase inhibitors: a narrative review
2个月前
已完结
皖公网安备34019202002308
